Physician profile
Eugene Becker
NPI 1871532317
$8,036.04
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $455 · 2021: $717 · 2022: $2,133 · 2023: $3,332 · 2024: $1,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,138 · Travel and Lodging: $1,459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,138.37 |
| Travel and Lodging | $1,458.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,943.86 | 2019-2024 | Wavewriter Alpha Prime 16, Artisan |
| Pacira Pharmaceuticals Incorporated | $948.33 | 2022 | |
| Abbvie INC. | $202.84 | 2022-2024 | Botox |
| Baudax Bio INC. | $177.84 | 2020-2022 | |
| Nevro Corp. | $170.25 | 2019-2021 | |
| Avanos Medical | $98.16 | 2022 | |
| Redhill Biopharma INC. | $68.84 | 2021-2023 | Aemcolo, Talicia, Movantik |
| Spr Therapeutics, INC | $65.00 | 2023 | Sprint Pns System |
| Horizon Therapeutics Plc | $58.75 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $58.53 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.29 | 2022-2023 | Relistor |
| Allergan, INC. | $35.11 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $28.99 | 2022 | |
| Stimwave Technologies Incorporated | $21.28 | 2021 | |
| Pfizer INC. | $20.34 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $19.53 | 2020 | |
| Ibsa Pharma INC. | $17.34 | 2023 | Tirosint, Licart |
| Lilly USA, LLC | $16.49 | 2022 | |
| Abbott Laboratories | $15.78 | 2021 | |
| Providence Medical Technology, INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.